Spanish Oncology Genito-urinary Group
Clinical trials sponsored by Spanish Oncology Genito-urinary Group, explained in plain language.
-
New drug combo aims to shrink bladder tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests erdafitinib alone or with cetrelimab before surgery in 90 people with muscle-invasive bladder cancer that has specific gene changes (FGFR). Participants cannot take standard cisplatin chemotherapy. The goal is to see if the drugs can eliminate or shrink t…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Real-World check: do new cancer drugs deliver outside trials?
Knowledge-focused Recruiting nowThis study follows 500 people with genitourinary cancers (like prostate, bladder, or kidney cancer) to see how well recently approved drugs work in everyday Spanish hospitals. Researchers will collect data from patients already taking these medications, without changing their tre…
Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC